(Q40391918)

20 September 2017

1 reference

title

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy (English)

1 reference

20 September 2017

1 reference

1

R N Brogden

1 reference

20 September 2017

D H Peters

2

1 reference

20 September 2017

publication date

1 May 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

47

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

823-854

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199447050-00008

20 September 2017

exact match

0 references

cites work

Teicoplanin vs cephradine and metronidazole in the prophylaxis of sepsis following vascular surgery: an interim analysis of an ongoing trial.

1 reference

12 December 2020

Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots

1 reference

12 December 2020

Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse

1 reference

12 December 2020

Spanish experience with teicoplanin

1 reference

12 December 2020

Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia

1 reference

12 December 2020

Effect of penicillin G on Staphylococcus aureus phagocytosed by human monocytes.

1 reference

12 December 2020

Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria

1 reference

12 December 2020

Recent trend and development of novel antimicrobial agents for MRSA infections

1 reference

12 December 2020

Evaluation of a novel fluorescence polarization immunoassay for teicoplanin

1 reference

12 December 2020

Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.

1 reference

12 December 2020

Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.

1 reference

12 December 2020

Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients.

1 reference

12 December 2020

Activity of vancomycin and teicoplanin against human polymorphonuclear leucocytes: a comparative study

1 reference

12 December 2020

In vitro activity of the new glycopeptide decaplanin.

1 reference

12 December 2020

Dosage recommendations for teicoplanin

1 reference

12 December 2020

The in-vivo activity of co-amoxiclav with netilmicin against experimental methicillin and gentamicin resistant Staphylococcus epidermidis infection in rabbits

1 reference

12 December 2020

The post-antibiotic effect of teicoplanin: monotherapy and combination studies

1 reference

12 December 2020

In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum

1 reference

12 December 2020

Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers

1 reference

12 December 2020

In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer

1 reference

12 December 2020

Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin

1 reference

12 December 2020

Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics.

1 reference

12 December 2020

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

1 reference

12 December 2020

Physical and chemical compatibility of intravenous ciprofloxacin with other drugs

1 reference

12 December 2020

Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.

1 reference

12 December 2020

4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin

1 reference

12 December 2020

The role of Gram-positive therapy in the neutropenic patient

1 reference

12 December 2020

In vitro activity of vancomycin and teicoplanin against gram-positive cocci

1 reference

12 December 2020

Antistaphylococcal activity of vancomycin and teicoplanin under anaerobic conditions

1 reference

12 December 2020

Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy

1 reference

12 December 2020

In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.

1 reference

12 December 2020

Teicoplanin Combined with Various Antibiotics and Human Blood against a Multiple-Drug-Resistant Strain of <i>Staphylococcus aureus</i>

1 reference

12 December 2020

Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics

1 reference

12 December 2020

A receptor-antibody sandwich assay for teicoplanin

1 reference

12 December 2020

Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

1 reference

12 December 2020

Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns

1 reference

12 December 2020

Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium

1 reference

12 December 2020

Influence of various antibiotics on phagocytosis of Staphylococcus aureus by human polymorphonuclear leucocytes

1 reference

12 December 2020

Determination of teicoplanin concentration in serum using a bioassay technique.

1 reference

12 December 2020

Erythroderma induced by teicoplanin

1 reference

12 December 2020

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis

1 reference

12 December 2020

In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)

1 reference

12 December 2020

Treatment of bone and soft tissue infections with teicoplanin.

1 reference

12 December 2020

In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.

1 reference

12 December 2020

In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods

1 reference

12 December 2020

Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections

1 reference

12 December 2020

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies

1 reference

12 December 2020

Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.

1 reference

12 December 2020

In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin

1 reference

12 December 2020

Prophylaxis, cost and effectiveness of therapy of infections caused by Gram-positive organisms in neutropenic children

1 reference

12 December 2020

Vancomycin-resistant leuconostocs, lactobacilli and now pediococci.

1 reference

12 December 2020

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

1 reference

12 December 2020

In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.

1 reference

12 December 2020

Genetics and mechanisms of glycopeptide resistance in enterococci

1 reference

12 December 2020

Teicoplanin monotherapy of serious infections caused by Gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial

1 reference

12 December 2020

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

1 reference

12 December 2020

Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin

1 reference

12 December 2020

In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics

1 reference

12 December 2020

Teicoplanin metabolism in humans

1 reference

12 December 2020

Efficacy, tolerability and pharmacokinetics of teicoplanin in patients undergoing breast surgery

1 reference

12 December 2020

Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus

1 reference

12 December 2020

Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis

1 reference

12 December 2020

Teicoplanin vs cephamandole for antimicrobial prophylaxis in prosthetic joint implant surgery: (preliminary results)

1 reference

12 December 2020

Bacteriolytic effect of teicoplanin

1 reference

12 December 2020

Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues

1 reference

12 December 2020

Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin

1 reference

12 December 2020

Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte

1 reference

12 December 2020

Novel membrane proteins present in teicoplanin-resistant, vancomycin sensitive, coagulase-negative Staphylococcus spp

1 reference

12 December 2020

Teicoplanin-resistant coagulase-negative staphylococci

1 reference

12 December 2020

Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci

1 reference

12 December 2020

Teicoplanin--domiciliary use in surgical infections

1 reference

12 December 2020

Bioassay for teicoplanin in peritoneal dialysis fluid

1 reference

12 December 2020

Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin

1 reference

12 December 2020

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

1 reference

12 December 2020

Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats

1 reference

12 December 2020

Teicoplanin nephrotoxicity: first case report.

1 reference

12 December 2020

Intracellular bactericidal activity of fosfomycin against staphylococci: A comparison with other antibiotics

1 reference

12 December 2020

Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus

1 reference

12 December 2020

LY146032: activity and resistance development in vitro.

1 reference

12 December 2020

Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus

1 reference

12 December 2020

In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters

1 reference

12 December 2020

Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery

1 reference

12 December 2020

Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay

1 reference

12 December 2020

Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers

1 reference

12 December 2020

Teicoplanin-resistant coagulase-negative staphylococcus

1 reference

12 December 2020

Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

1 reference

12 December 2020

In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents

1 reference

12 December 2020

Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses

1 reference

12 December 2020

[Vancomycin and "red man's syndrome". Presentation of a clinical case]

1 reference

12 December 2020

Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection

1 reference

12 December 2020

Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1

1 reference

12 December 2020

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis

1 reference

12 December 2020

Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine

1 reference

12 December 2020

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

1 reference

12 December 2020

Intravenous or Intramuscular Teicoplanin Once Daily for Skin and Soft-Tissue Infections

1 reference

12 December 2020

Pharmacokinetics of individual components of teicoplanin in man.

1 reference

12 December 2020

Model choice for teicoplanin kinetics in man

1 reference

12 December 2020

A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters.

1 reference

12 December 2020

Influence of the pre-treatment duration of infection on the efficacies of various antibiotic regimens in experimental streptococcal endocarditis

1 reference

12 December 2020

Infections due to Gram-positive organisms in children: possible role for teicoplanin

1 reference

12 December 2020

Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates

1 reference

12 December 2020

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci

1 reference

12 December 2020

Penetration into tissues of various drugs active against gram-positive bacteria

1 reference

12 December 2020

Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients

1 reference

12 December 2020

Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis

1 reference

12 December 2020

Aminoglycoside toxicity following antibiotic prophylaxis in cardiac surgery.

1 reference

12 December 2020

Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus

1 reference

12 December 2020

Susceptibility of Staphylococcus species and subspecies to teicoplanin

1 reference

12 December 2020

The bactericidal activity of vancomycin and teicoplanin against Streptococcus pneumoniae.

1 reference

12 December 2020

An Open Study of Teicoplanin in the Treatment of Gram-Positive Infections

1 reference

12 December 2020

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients

1 reference

12 December 2020

Anaphylactoid reactions to glycopeptide antibiotics

1 reference

12 December 2020

In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients

1 reference

12 December 2020

Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility

1 reference

12 December 2020

The pharmacokinetics of teicoplanin in varying degrees of renal function

1 reference

12 December 2020

In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile

1 reference

12 December 2020

The potential impact on clinical practice of differences in the in-vitro activity of vancomycin and teicoplanin

1 reference

12 December 2020

Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis

1 reference

12 December 2020

The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria

1 reference

12 December 2020

In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis

1 reference

12 December 2020

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

1 reference

12 December 2020

Erysipelothrix rhusiopathiae: an occupational pathogen

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans

1 reference

12 December 2020

Performance of a fluorescence polarization immunoassay for teicoplanin in serum.

1 reference

12 December 2020

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

1 reference

12 December 2020

Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats

1 reference

12 December 2020

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

1 reference

12 December 2020

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

1 reference

12 December 2020

Clinical evaluation of teicoplanin fluorescence polarization immunoassay

1 reference

12 December 2020

Teicoplanin in gram-positive infection: microbiological aspects.

1 reference

12 December 2020

The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus

1 reference

12 December 2020

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

1 reference

12 December 2020

A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci

1 reference

12 December 2020

Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates

1 reference

12 December 2020

Intraphagocytic penetration of antibiotics

1 reference

12 December 2020

Influence of teicoplanin and vancomycin on degranulation by polymorphonuclear leucocytes stimulated by various agonists: an in-vitro study

1 reference

12 December 2020

High-level resistance to aminoglycosides in enterococci; incidence and alternative active antibiotic combinations in vitro

1 reference

12 December 2020

Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections

1 reference

12 December 2020

In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function

1 reference

12 December 2020

Allergic cross-reaction of teicoplanin and vancomycin

1 reference

12 December 2020

Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method

1 reference

12 December 2020

Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.

1 reference

12 December 2020

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies

1 reference

12 December 2020

A review of the safety profile of teicoplanin

1 reference

12 December 2020

IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin

1 reference

12 December 2020

Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin

1 reference

12 December 2020

HPLC quantitation of the six main components of teicoplanin in biological fluids

1 reference

12 December 2020

Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution

1 reference

12 December 2020

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium

1 reference

12 December 2020

Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis

1 reference

12 December 2020

In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.

1 reference

12 December 2020

Allergic cross-reactivity to teicoplanin and vancomycin

1 reference

12 December 2020

Efficacy of teicoplanin for enterococcal infections: 63 cases and review

1 reference

12 December 2020

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

1 reference

12 December 2020

Red Man Syndrome with Teicoplanin

1 reference

12 December 2020

Cost implications of home care on serious infections.

1 reference

12 December 2020

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

1 reference

12 December 2020

Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses

1 reference

12 December 2020

Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States

1 reference

12 December 2020

Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin

1 reference

12 December 2020

In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.

1 reference

12 December 2020

10.2165/00003495-199447050-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1002550201

0 references

1 reference